Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB – IVA mycosis fungoides/Sézary syndrome

2016 ◽  
Vol 175 (1) ◽  
pp. 80-88 ◽  
Author(s):  
F. Child ◽  
P.L. Ortiz‐Romero ◽  
R. Alvarez ◽  
M. Bagot ◽  
R. Stadler ◽  
...  
Keyword(s):  
Histone Deacetylase ◽  
Mycosis Fungoides ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Multicentre Trial ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
Stage Ib ◽  
Deacetylase Inhibitor ◽  
Previously Treated

scholarly journals Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer

Oral Oncology ◽  
2012 ◽  
Vol 48 (12) ◽  
pp. 1281-1288 ◽  
Author(s):  
Missak Haigentz ◽  
Mimi Kim ◽  
Catherine Sarta ◽  
Juan Lin ◽  
Roger S. Keresztes ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Neck Cancer ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document